Lisa Miller | Senior Director, IR |
Richard Hawkins | CEO & Chairman |
John McKew | Chief Scientific Officer & President |
David Karpf | Chief Medical Officer |
Lori Lawley | CFO & Principal Accounting Officer |
Avraham Novick | Cantor Fitzgerald & Co. |
Yasmeen Rahimi | Piper Sandler & Co. |
Catherine Novack | JonesTrading Institutional Services |
Edward White | H.C. Wainwright & Co. |
Good afternoon, and welcome to Lumos Pharma's First Quarter 2022 Results & Clinical Update Conference Call. [Operator Instructions].
As a reminder, this conference call is being recorded. I'd now like to turn the call over to Lisa Miller, Senior Director of Investor Relations. Please go ahead.